These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12007018)

  • 21. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
    Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
    Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
    J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data.
    Koh KN; Han JW; Choi HS; Kang HJ; Lee JW; Yoo KH; Sung KW; Koo HH; Hong KT; Choi JY; Kang SH; Kim H; Im HJ; Hahn SM; Lyu CJ; Baek HJ; Kook H; Park KM; Yang EJ; Lim YT; Kim S; Lee JW; Chung NG; Cho B; Park M; Park HJ; Park BK; Lee JA; Park JE; Kim SK; Kim JY; Kim HS; Ma Y; Park KD; Park SK; Park ES; Shim YJ; Yoo ES; Ryu KH; Yoo JW; Lim YJ; Yoon HS; Lee MJ; Lee JM; Jeon IS; Jung HL; Chueh HW; Won S;
    Cancer Res Treat; 2023 Jan; 55(1):279-290. PubMed ID: 35952715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.
    Sourvinos G; Spandidos DA
    Biochem Biophys Res Commun; 1998 Apr; 245(1):75-80. PubMed ID: 9535786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues.
    Argani P; Kao YC; Zhang L; Bacchi C; Matoso A; Alaggio R; Epstein JI; Antonescu CR
    Am J Surg Pathol; 2017 Dec; 41(12):1702-1712. PubMed ID: 28817404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
    Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
    Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.
    Wegert J; Vokuhl C; Collord G; Del Castillo Velasco-Herrera M; Farndon SJ; Guzzo C; Jorgensen M; Anderson J; Slater O; Duncan C; Bausenwein S; Streitenberger H; Ziegler B; Furtwängler R; Graf N; Stratton MR; Campbell PJ; Jones DT; Koelsche C; Pfister SM; Mifsud W; Sebire N; Sparber-Sauer M; Koscielniak E; Rosenwald A; Gessler M; Behjati S
    Nat Commun; 2018 Jun; 9(1):2378. PubMed ID: 29915264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour.
    Portugal R; Barroca H
    Cytopathology; 2008 Apr; 19(2):80-5. PubMed ID: 17681013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic and molecular characterization of a congenital mesoblastic nephroma.
    Ramachandran C; Melnick SJ; Escalon E; Khatib Z; Jhabvala P; Fonseca HB; Smith S; Alamo A; Medina S
    Pediatr Dev Pathol; 2001; 4(4):402-11. PubMed ID: 11441343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.
    Pruneri G; Carboni N; Baldini L; Intini D; Colombi M; Bertolini F; Valentini S; Maisonneuve P; Viale G; Neri A
    Hum Pathol; 2003 Jan; 34(1):41-7. PubMed ID: 12605365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicystic congenital mesoblastic nephroma.
    Drut R
    Int J Surg Pathol; 2002 Jan; 10(1):59-63. PubMed ID: 11927972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene.
    Wu L; Levine AJ
    Mol Med; 1997 Jul; 3(7):441-51. PubMed ID: 9260156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.
    Cocker HA; Pinkerton CR; Kelland LR
    Br J Cancer; 2000 Aug; 83(3):338-45. PubMed ID: 10917549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine needle aspiration cytology characteristics of renal tumors in children.
    Sharifah NA
    Pathology; 1994 Oct; 26(4):359-64. PubMed ID: 7892032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.
    García JF; Piris MA; Lloret E; Orradre JL; Murillo PG; Martínez JC
    Histopathology; 1997 Feb; 30(2):120-5. PubMed ID: 9067734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital mesoblastic nephroma: report of a Case with review of the most significant literature.
    Bisceglia M; Carosi I; Vairo M; Zaffarano L; Bisceglia M; Creti G
    Pathol Res Pract; 2000; 196(3):199-204. PubMed ID: 10729925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.